SSTR2 and neoplasm: However, the low expression levels of ZAC1 and SSTR2 may be involved in the resistance to somatostatin analogs that is observed in these tumors, partially justifying the failure of tumor shrinkage that is observed in NFPA compared to somatotropinomas.